Bamocaftor potassiumProduct ingredient for Bamocaftor

Show full entry for Bamocaftor
Name
Bamocaftor potassium
Drug Entry
Bamocaftor

Bamocaftor (VX-659) is under investigation in clinical trial NCT03224351 (A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis).

See full entry for Bamocaftor
Accession Number
DBSALT003367
Structure
Synonyms
Potassium (benzenesulfonyl)(((6-(3-(2-(1-(trifluoromethyl)cyclopropyl)ethoxy)-1H-pyrazol-1-yl)-2-((4S)-2,2,4-trimethylpyrrolidin-1-yl)pyridin-3-yl)carbonyl))azanide / VX-659 potassium
UNII
Not Available
CAS Number
Not Available
Not Available
Predicted Properties
Not Available